 Dupont Capital Management Corp purchased a new position in Concert Pharmaceuticals Inc NASDAQ:CNCE during the second quarter, HoldingsChannel reports. The institutional investor purchased 30,525 shares of the biotechnology companys stock, valued at approximately 304,000. Other large investors have also modified their holdings of the company. BNP Paribas Arbitrage SA boosted its stake in Concert Pharmaceuticals ... 